mindstrong-logo-ko-200px

Mindstrong is redefining behavioral healthcare by transforming how we diagnose and manage these disorders to improve outcomes.

Founders

Mindstrong was founded by some of the world’s leading authorities in neuroscience, oncology, and technology. It is based on their shared vision to redefine neuropsychiatric healthcare, transforming diagnosis and delivering precision therapy. Mindstrong builds on one of the founder’s patented biomarker platform developed over years of extensive clinical R&D.

Paul Dagum, MD PhD

FOUNDER AND CHIEF EXECUTIVE OFFICER

Paul Dagum, M.D., Ph.D. is an entrepreneur, scientist and technologist with a track record of creating and launching product in three successful venture-backed companies. Dr. Dagum led NSF and NIH grants while at Stanford University, published over 70 peer-review articles and book chapters in computer science and medicine, and was awarded over 20 patents. Dr. Dagum received an MSc in theoretical physics, PhD in theoretical computer science both from the University of Toronto and an MD from Stanford University.

Tom Insel, MD

FOUNDER AND PRESIDENT

Thomas R. lnsel, M.D. is a psychiatrist and neuroscientist.  From 2002-2015, Dr. Insel served as Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders. Most recently he led the Mental Health Team at Verily. Dr. Insel is a member of the National Academy of Medicine and has received numerous national and international awards including honorary degrees in the U.S. and Europe.

Rick Klausner, MD

FOUNDER AND EXECUTIVE CHAIRMAN

Richard D. Klausner is founder and Director of Juno Therapeutics and founder and Director of GRAIL. Dr. Klausner was appointed by Presidents Clinton and Bush as the eleventh Director of the U.S. National Cancer Institute between 1995 and 2001. Dr. Klausner served as chief of the Cell Biology and Metabolism Branch of the National Institute of Child Health and Human Development as well as a past president of the American Society of Clinical Investigation. He is a member of the National Academy of Sciences, the Institute of Medicine and the American Academy of Arts and Sciences.

Board of Directors

Mindstrong’s Board of Directors brings deep experience working at the intersection of academia and industry.

Rick Klausner, MD

FOUNDER AND EXECUTIVE CHAIRMAN, MINDSTRONG HEALTH

Jim Tananbaum, MD

CEO AND FOUNDER, FORESITE CAPITAL

Michael Weintraub

MANAGING DIRECTOR, OPTUM VENTURES

Robert Epstein, MD

CEO, EPSTEIN HEALTH

Tom Insel, MD

FOUNDER AND PRESIDENT, MINDSTRONG HEALTH

Paul Dagum, MD PhD

FOUNDER AND CHIEF EXECUTIVE OFFICER, MINDSTRONG HEALTH

Investors

Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.

FORESITE CAPITAL

ARCH VENTURE PARTNERS

OPTUM VENTURES

BERGGRUEN HOLDINGS

ONE MIND BRAIN HEALTH IMPACT FUND

Intellectual Property

Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.

Contact Us

Whether you are looking to learn more about Mindstrong, or looking to join a dynamic team of dedicated people, reach out to us via phone, email or the form below and we'll be in touch.

ADDRESS

248 Homer Ave
Palo Alto, CA 94301

Please enter your name.
Please enter a message.